Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImperial Innovations Group Regulatory News (IVO)

  • There is currently no data for IVO

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Touchstone invests £1.4m in Featurespace round

4 Oct 2017 07:00

RNS Number : 6116S
Touchstone Innovations PLC
04 October 2017
 

 

4 October 2017

 

Touchstone Innovations plc

 

Touchstone invests £1.4m in £16.5m funding round in Featurespace, the machine learning fraud prevention company

 

Touchstone Innovations plc (AIM: IVO, 'the Group', 'Touchstone') has participated in a £16.5m funding round in Featurespace Limited ("Featurespace" or "the Company"), a leading machine-learning, fraud prevention company.

 

Touchstone has committed £1.4 million to the round, which was led by Highland Europe. The round was also supported by Worldpay Group plc, a leading global payment processing company, and Invoke Capital, a technology investment company. The new funding will enable Featurespace to drive revenues of its product platform and to continue to expand internationally.

 

Following this new investment, Touchstone will hold a 27.9% interest in the Company. The current valuation, including this investment is £15.6 million.

 

Featurespace, based in Cambridge, is an Adaptive Behavioural Analytics company that is addressing the fast-growing fraud detection and prevention market. According to MarketsandMarkets, this market was worth $14.8bn in 2014 and is growing at 18% per annum.

 

The Company has developed a machine learning software platform, ARIC, that identifies abnormal behaviour in high-volume, real-time customer interactions. Through analysing every individual customer interaction and understanding normal behaviour, Featurespace helps to protect customers from fraud attack, and reduces the costs of lost transactions.

 

Featurespace has developed an ambitious growth plan, which focuses on expanding further within the UK and the USA. The business recently opened offices in North Carolina and New York, and last year signed a deal with TSYS, one of the largest payments processors in the US, in which Featurespace's adaptive behavioural analytics platform is being used to reduce fraud for TSYS' clients. The injection of new capital from this funding round will enable the Company to pursue further sales through this channel as well as direct sales to new customers in both existing and new markets.

 

Martina King, CEO of Featurespace, said:

"We are working with our clients to protect businesses and consumers in the fight against fraud. This funding round will enable us to continue to grow our business internationally, building on our progress as a leader in machine learning fraud prevention."

Jon Edington, Director of Technology Ventures at Touchstone Innovations, added:

 

"Featurespace is a business with world-class machine-learning technology married to a management team with an excellent track record, and has the potential to be a substantial international entity.

 

"The evolution and development of Featurespace is a classic example of our approach.

 

"We initially worked with the late Professor Bill Fitzgerald who was head of signal processing and applied statistics at the University of Cambridge and Dave Excell, his PhD student, to develop the technology and concept and made our initial investment into the Company in 2012.

"Subsequently, we have continued to support the business with further funding as well as helping to recruit the management team with the right expertise and experience.

 

"More recently we have sought to build a strong syndicate around the business, widening the pool of investors and bringing in industry expertise.

 

"Today's news reflects the growing maturity of the business and its potential for growth."

 

-Ends-

 

For further information contact:

 

Touchstone Innovations plc

020 3053 8834

Russ Cummings, Chief Executive Officer

 

Jon Davies, Director of Communications

 

 

 

Instinctif Partners

020 7457 2020

Adrian Duffield/Melanie Toyne-Sewell/Chantal Woolcock

 

 

 

J.P. Morgan Cazenove (Nominated Adviser)

020 7742 4000

Michael Wentworth-Stanley/Alec Pratt

 

 

 

RBC Capital Markets

020 7653 4000

Darrell Uden/Marcus Jackson/Laura White

 

 

 

About Touchstone Innovations - www.touchstoneinnovations.com

 

Touchstone Innovations plc ("Touchstone" formerly Imperial Innovations Group plc) creates, builds and invests in pioneering technology companies and licensing opportunities developed from outstanding scientific research from the Golden Triangle, the region broadly bounded by London, Cambridge and Oxford.

 

This area has an unrivalled cluster of outstanding academic research and technology businesses, and is home to four of the world's top 10 universities, as well as leading research institutions, the cream of the UK's science and technology businesses and many of its leading investors.

 

Touchstone supports scientists and entrepreneurs in the commercialisation of their ideas through protecting and licensing out intellectual property (through its Technology Transfer subsidiary, Imperial Innovations Limited), by leading the formation of new companies, by recruiting high-calibre management teams and by providing investment and encouraging co-investment. Touchstone remains an active investor over the life of its portfolio companies, with the majority of Touchstone's investment going into businesses in which it is already a shareholder.

 

Since becoming a public company in 2006, Touchstone has raised more than £440.0 million of equity from investors, which has enabled it to invest in some of the most exciting spin-outs to come out of UK academic research. In addition, the Group has a £74.4 million term debt facility from the European Investment Bank (EIB).

 

Between Touchstone's admission to AIM (August 2006) and 31 July 2017, Touchstone has invested a total of £372.4 million across its portfolio companies, currently valued at £461.1 million and in addition has generated £51.0 million of cash realisations. In aggregate, Touchstone's portfolio, excluding Apollo Therapeutics and UCL Technology Fund, has collectively raised investment of more than £1.7 billion.

 

 

About Featurespace - www.featurespace.co.uk

 

Featurespace™ is the world-leader in Adaptive Behavioral Analytics and creator of the ARIC™ platform, a real-time machine learning software system developed out of the University of Cambridge.

 

The ARIC™ platform - a real-time, machine learning software system - monitors individual behaviors to catch new fraud attacks as they happen. At the same time, the increased accuracy of understanding customer behavior reduces the number of genuine customers whose purchases and transactions are incorrectly declined.

 

Featurespace is based in Cambridge, UK, and the Company has deployed ARIC™ to organizations that have services or products deployed in over 180 countries.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFSUFMDFWSEFS
Date   Source Headline
26th Oct 20077:24 amPRNGBP30m Placing
27th Sep 20077:04 amRNSInvestment in EVO Electric
27th Sep 20077:00 amPRNFinal Results
24th Sep 20072:44 pmRNSThe Engineer Awards
12th Sep 20078:00 amPRNNotice of Preliminary Results
31st Aug 20079:00 amRNSInvestment in MVL
7th Aug 20079:00 amRNSionscope raises funds
3rd Aug 200710:25 amRNSInvestment in Veryan Medical
3rd Aug 20078:00 amRNSInvestment in Veryan Medical
1st Aug 20075:31 pmRNSInvestment in Nexeon Ltd
30th Jul 20078:00 amRNSInvestment in Acrobot Ltd
11th Jul 20079:37 amRNSInvestment in AML
6th Jul 20078:10 amRNSInvestment in NanoBioDesign
28th Jun 20077:02 amRNSInvestment in QuantaSol
25th Jun 200710:00 amRNSCall For Recycling Inventions
20th Jun 200711:21 amRNSInvestment in PolyTherics
14th Jun 20072:31 pmRNSInvestment in Midaz Lasers
6th Jun 20073:11 pmRNSPSE Wins MacRobert Award
5th Jun 200711:03 amRNSPSE - Awards Finalist
23rd May 20078:00 amRNSInvestment in IXICO Ltd
11th May 200710:00 amRNSInvestment in Veryan Medical
9th May 200710:04 amRNSMDi Licensing Deal
27th Apr 20077:01 amRNSLaunch of Funding Programme
27th Apr 20077:01 amRNSInterim Results
30th Mar 20078:00 amRNSInvestment in Cell Medica
27th Mar 200710:22 amRNSStormBio Licensing Deal
23rd Mar 20078:00 amRNSNotice of Results
22nd Mar 200711:53 amRNSHolding(s) in Company
16th Mar 200710:44 amRNSHolding(s) in Company
15th Mar 20079:00 amRNSIncubation of Stoneglass
12th Mar 20078:00 amRNSIonscope Sells First Products
8th Mar 20079:20 amRNSHolding(s) in Company
7th Mar 20078:00 amRNSChinese Strategic Partnership
13th Feb 20078:00 amRNSIncubation of Rubber-Regen
9th Feb 20073:05 pmRNSHolding(s) in Company
8th Feb 20072:58 pmRNSHolding(s) in Company
1st Feb 20077:00 amRNSInvestment in ATT Ltd
29th Jan 20077:01 amRNSInvestment in Circassia
25th Jan 200712:59 pmRNSResult of AGM
12th Jan 20079:00 amRNSInvestment in Equinox Pharma
21st Dec 200612:13 pmRNSTotal Voting Rights
18th Dec 20064:53 pmRNSHolding(s) in Company
8th Dec 20067:00 amRNSAnnual Report and Accounts
21st Nov 20067:01 amRNSDirector/PDMR Shareholding
16th Nov 20067:01 amRNSBAE Systems Contract
16th Nov 20067:01 amRNSFinal Results
2nd Nov 20068:00 amRNSImperial BioIncubator
26th Oct 20067:01 amRNSNotice of Results
23rd Oct 20064:17 pmRNSDisposal
18th Oct 20067:00 amRNSLow Carbon Seed Fund

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.